Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-18 8:04 pm Purchase |
2022-05-10 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
US VENTURE PARTNERS X LP | 179,223 10.800% |
179,223 (New Position) |
Filing History |
| 2022-08-18 7:54 pm Sale |
2022-08-09 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
US VENTURE PARTNERS X LP | 0 0.000% |
-192,885 (Position Closed) |
Filing History |
| 2022-01-27 3:09 pm Sale |
2021-12-31 | 13G | Inari Medical, Inc. NARI |
US VENTURE PARTNERS X LP | 521,864 1.000% |
-5,219,298 (-90.91%) |
Filing History |
| 2021-09-13 06:23 am Purchase |
2021-08-25 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
US VENTURE PARTNERS X LP | 192,885 11.900% |
192,885 (New Position) |
Filing History |
| 2021-02-08 7:00 pm Purchase |
2020-12-31 | 13G | Inari Medical, Inc. NARI |
US VENTURE PARTNERS X LP | 5,741,162 11.800% |
5,741,162 (New Position) |
Filing History |